Sanofi India Ltd Q1 CY2024 net profit declines to Rs. 136.6 crores

Sanofi India Limited has reported Standalone financial results for the period ended March 31, 2024.

Financial Results (Q1 CY2024) - QoQ Comparison

The company has reported total income of Rs. 738.9 crores during the period ended March 31, 2024 as compared to Rs. 705.9 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. 136.6 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 137.7 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. 59.31 for the period ended March 31, 2024 as compared to Rs. 59.79 for the period ended December 31, 2023.

Financials	Q1 CY2024	Q4 CY2023	% Change
Total Income	₹738.9 crs	₹705.9 crs	4.67%
Net Profit	₹136.6 crs	₹137.7 crs	-0.80%
EPS	₹59.31	₹59.79	-0.80%

Financial Results (Q1 CY2024) - YoY Comparison

The company has reported total income of Rs.738.9 crores during the period ended March 31, 2024 as compared to Rs.762.3 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.136.6 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.190.4 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.59.31 for the period ended March 31, 2024 as compared to Rs.82.67 for the period ended March 31, 2023.

Financials	Q1 CY2024	Q1 CY2023	% Change
Total Income	₹738.9 crs	₹762.3 crs	-3.07%
Net Profit	₹136.6 crs	₹190.4 crs	-28.26%
EPS	₹59.31	₹82.67	-28.26%

Shares of Sanofi India Limited was last trading in BSE at Rs. 7987.85 as compared to the previous close of Rs. 8020.50. The total number of shares traded during the day was 3290 in over 1181 trades.

The stock hit an intraday high of Rs. 8160.40 and intraday low of 7780.00. The net turnover during the day was Rs. 26282606.00.

Source : Equity Bulls

Keywords

SanofiIndia Q4FY24 FY2024 ResultUpdate